Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic c... von Loriot, Yohann, Dr, Miller, Kurt, Prof, Sternberg, Cora N, Prof, Fizazi, Karim, Prof, De Bono, Johann S, Prof, Chowdhury, Simon, PhD, Higano, Celestia S, MD, Noonberg, Sarah, MD, Holmstrom, Stefan, MSc, Mansbach, Harry, MD, Perabo, Frank G, MD, Phung, De, BSc, Ivanescu, Cristina, PhD, Skaltsa, Konstantina, PhD, Beer, Tomasz M, Prof, Tombal, Bertrand, Prof

Volltext

Targeting the N‐Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer von Antonarakis, Emmanuel S., Chandhasin, Chandtip, Osbourne, Erica, Luo, Jun, Sadar, Marianne D., Perabo, Frank

Volltext

Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study von Tombal, Bertrand, Prof, Borre, Michael, Prof, Rathenborg, Per, MD, Werbrouck, Patrick, MD, Van Poppel, Hendrik, Prof, Heidenreich, Axel, Prof, Iversen, Peter, Prof, Braeckman, Johan, Prof, Heracek, Jiri, MD, Baskin-Bey, Edwina, MD, Ouatas, Taoufik, PhD, Perabo, Frank, MD, Phung, De, BSc, Hirmand, Mohammad, MD, Smith, Matthew R, Prof

Volltext

TACH101, a first-in-class pan-inhibitor of KDM4 for treatment of gastrointestinal cancers von Perabo, Frank, Chandhasin, Chandtip, Yoo, Sanghee, Dang, Van, Del Rosario, Joselyn, Chen, Young K, Stafford, Jeffrey, Quake, Stephen, Clarke, Michael F.

Volltext

Antiproliferative and apoptosis inducing effects of indirubin-3′-monoxime in renal cell cancer cells von Perabo, Frank G.E., M.D., Ph.D, Landwehrs, Gregor, M.D, Frössler, Christian, M.D, Schmidt, Doris H., B.Sc, Mueller, S.C., M.D., Ph.D

Volltext

Lessons learned from the metastatic castration-resistant prostate cancer phase I trial of EPI-506, a first-generation androgen receptor N-terminal domain inhibitor von Le Moigne, Ronan, Zhou, Han-Jie, Obst, Jon K., Banuelos, C. Adriana, Jian, Kunzhong, Williams, David, Virsik, Peter, Andersen, Raymond J, Sadar, Marianne, Perabo, Frank, Chi, Kim N.

Volltext

Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer von PERABO, Frank G. E, FRÖSSLER, Christian, LANDWEHRS, Gregor, SCHMIDT, Doris H, VON RÜCKER, Alexander, WIRGER, Andreas, MÜLLER, Stefan C

Volltext

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity von Ellinger, Jörg, Bastian, Patrick J, Ellinger, Nadja, Kahl, Philip, Perabo, Frank G, Büttner, Reinhard, Müller, Stefan C, Ruecker, Alexander von

Volltext

Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer von Perabo, Frank G.E., Willert, Patricia L., Wirger, Andreas, Schmidt, Doris H., Wardelmann, Eva, Sitzia, Mario, von Ruecker, Alexander, Mueller, Stefan C.

Volltext

Drug development for LUTS – The challenge for industry von Perabo, Frank G.E

Volltext

Treatment of penile strangulation caused by constricting devices von Perabo, Frank G.E, Steiner, Gabriel, Albers, Peter, Müller, Stefan C

Volltext

Flavopiridol, an Inhibitor of Cyclin-dependent Kinases, Induces Growth Inhibition and Apoptosis in Bladder Cancer Cells In Vitro and In Vivo von WIRGER, Andreas, PERABO, Frank G. E, BURGEMEISTER, Susanne, HAASE, Ludwig, SCHMIDT, Doris H, DOEHN, Christian, MUELLER, Stefan C, JOCHAM, Dieter

Volltext

Current and new strategies in immunotherapy for superficial bladder cancer von Perabo, Frank G.E., Müller, Stefan C.

Volltext

Facts and Fiction of Phytotherapy for Prostate Cancer: A Critical Assessment of Preclinical and Clinical Data von EVA C. VON LÖW, FRANK G.E. PERABO, ROSWITHA SIENER, STEFAN C. MÜLLER

Volltext

Superantigen-activated Mononuclear Cells Induce Apoptosis in Transitional Cell Carcinoma von PERABO, Frank G. E, WILLERT, Patricia L, WIRGER, Andreas, SCHMIDT, Doris H, VON RUECKER, Alexander, MUELLER, Stefan C

Volltext

Carboxyamido-triazole (CAI), a Signal Transduction Inhibitor Induces Growth Inhibition and Apoptosis in Bladder Cancer Cells by Modulation of Bcl-2 von PERABO, Frank G. E, WIRGER, Andreas, KAMP, Stefan, LINDNER, Heike, SCHMIDT, Doris H, MÜLLER, Stefan C, KOHN, Elise C

Volltext

Deutenzalutamide, an oral deuterated androgen receptor inhibitor, vs placebo for patients with mCRPC who have experienced treatment failure with abiraterone and docetaxel: Results... von Ye, Ding-Wei, Gu, Chengyuan, Hua, Lixin, Liu, Ranlu, Li, Jun, Qiu, Mingxing, Guo, Jianming, Dong, Haiying, Ji, Zhigang, Guo, Hong, Perabo, Frank, Chen, Yuanwei, Li, Xinghai

Volltext

Abstract 2128: TACH101, a first-in-class pan inhibitor of KDM4 histone lysine demethylases von Yoo, Sanghee, Chandhasin, Chandtip, Rosario, Joselyn R. Del, Chen, Young K., Stafford, Jeff, Quake, Stephen, Perabo, Frank, Clarke, Michael F.

Volltext

Pharmacologic characterization of TACH101, a first-in-class KDM4 inhibitor for development as a cancer therapeutic von Yoo, Sanghee, Chandhasin, Chandtip, Del Rosario, Joselyn, Chen, Young K, Stafford, Jeffrey, Perabo, Frank, Clarke, Michael F.

Volltext

Inhibition of histone lysine demethylases with TACH101, a first-in-class pan-inhibitor of KDM4 von Chandhasin, Chandtip, Yoo, Sanghee, Del Rosario, Joselyn, Chen, Young K, Stafford, Jeffrey, Perabo, Frank, Clarke, Michael F.

Volltext